These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15733528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG.
    Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
    [No Abstract] [Full Text] [Related]

  • 7. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
    Thomson AB, Wright JP, Vatn M, Bailey RJ, Rachmilewitz D, Adler M, Wilson-Lynch KA.
    Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of postoperative recurrence in Crohn's disease.
    Terdiman JP.
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):616-20. PubMed ID: 17967564
    [No Abstract] [Full Text] [Related]

  • 13. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP, Laegemidler F, Eskerod O.
    Ugeskr Laeger; 2005 Mar 14; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract] [Full Text] [Related]

  • 14. [Mesalazine is effective in Crohn disease 1].
    Fallingborg J, Langholz E, Christensen LA, Munkholm P, Dahlerup JF.
    Ugeskr Laeger; 2005 Mar 14; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
    [No Abstract] [Full Text] [Related]

  • 15. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M, Cammà C.
    Gastroenterology; 2000 Aug 14; 119(2):597. PubMed ID: 10960274
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW, Sandborn WJ.
    Gastroenterology; 1999 May 14; 116(5):1263. PubMed ID: 10220523
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Mesalazine is without clinical effect in patients with Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Jan 17; 167(3):302-3. PubMed ID: 15704804
    [No Abstract] [Full Text] [Related]

  • 19. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP, Rumiantsev VG.
    Eksp Klin Gastroenterol; 2006 Jan 17; (3):56-60. PubMed ID: 17203844
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.